DALGAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dalgan, and what generic alternatives are available?
Dalgan is a drug marketed by Astrazeneca and is included in one NDA.
The generic ingredient in DALGAN is dezocine. There is one drug master file entry for this compound. Additional details are available on the dezocine profile page.
Summary for DALGAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Clinical Trials: | 1 |
Patent Applications: | 5,378 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DALGAN at DailyMed |
Recent Clinical Trials for DALGAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jian-jun Yang | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for DALGAN
US Patents and Regulatory Information for DALGAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-001 | Dec 29, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-002 | Dec 29, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-003 | Dec 29, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DALGAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-003 | Dec 29, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-001 | Dec 29, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | DALGAN | dezocine | INJECTABLE;INJECTION | 019082-002 | Dec 29, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DALGAN
See the table below for patents covering DALGAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0180303 | PARENTERAL COMPOSITION | ⤷ Try a Trial |
Japan | H0621060 | ⤷ Try a Trial | |
Japan | S6185314 | NON-ORAL ADMINISTRATION COMPOSITION | ⤷ Try a Trial |
New Zealand | 213573 | PARENTERAL COMPOSITION CONTAINING DEZOCINE | ⤷ Try a Trial |
Cyprus | 1511 | PARENTERAL DEZOCINE COMPOSITIONS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |